SPEVIGO
NDC 0597-0620, spesolimab-sbzo, injection, from Boehringer Ingelheim Pharmaceuticals, Inc..
- Product NDC
- 0597-0620
- Status
- Listed
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761244
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0620 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SPESOLIMAB150 mg/1
Pharmacologic classes
Interleukin-36 Receptor Antagonist [EPC]; Interleukin-36 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0597-0620-20 | 00597062020 | 2 SYRINGE in 1 CARTON (0597-0620-20) / 150 INJECTION in 1 SYRINGE (0597-0620-10) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/41a481ee-3062-45d1-aed5-17e8b105634dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0597-0620
Use it
Look up 0597-0620 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0620 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0597-0620. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.